Together these evidences support the hypothesis that interfering with miRNA-mediated inhibition may restore the tumor-suppressive function of DAB2IP and revert aggressive phenotypes caused by the loss of its function both in tumor and in nearby stromal cells. The gene discussed is DAB2IP; the disease is neoplasm.